<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Adolescent <z:hpo ids='HP_0001513'>obesity</z:hpo> has dramatically increased in recent decades, and along with that so have other medical comorbidities, such as <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, <z:e sem="disease" ids="C0400966" disease_type="Disease or Syndrome" abbrv="">nonalcoholic steatohepatitis</z:e>, <z:hpo ids='HP_0000147'>polycystic ovary</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>), and <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> and related comorbidites may be contraindications to hormonal contraception, making contraception counseling of morbidly <z:mp ids='MP_0001261'>obese</z:mp> adolescents more challenging </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> adolescent females seeking bariatric surgery need effective contraception in the postoperative period </plain></SENT>
<SENT sid="3" pm="."><plain>This study is designed to determine the acceptance rate of the <z:chebi fb="0" ids="6443">levonorgestrel</z:chebi>-releasing intrauterine device (IUD) and describe common menstrual problems in <z:mp ids='MP_0001261'>obese</z:mp> adolescent bariatric surgery patients </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: This is a historic cohort study of adolescent females who underwent bariatric surgery over a 2-year period at a tertiary referral center for pediatric <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Data were systematically abstracted </plain></SENT>
<SENT sid="6" pm="."><plain>The percent of patients with menstrual problems and the acceptance rate for the <z:chebi fb="0" ids="6443">levonorgestrel</z:chebi>-releasing IUD were determined </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Twenty-five adolescents met inclusion criteria </plain></SENT>
<SENT sid="8" pm="."><plain>The mean age was 17.4 years (standard deviation [SD] 2.6), and the mean body mass index (BMI) was 51.4 (SD 6.3) kg/m(2) </plain></SENT>
<SENT sid="9" pm="."><plain>Eighty-four percent were white </plain></SENT>
<SENT sid="10" pm="."><plain>Twenty-eight percent had <z:hpo ids='HP_0000132'>menorrhagia</z:hpo>, 32% had <z:hpo ids='HP_0000876'>oligomenorrhea</z:hpo>, 40% had <z:hpo ids='HP_0100607'>dysmenorrhea</z:hpo>, and 36% had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Ninety-two percent (23 of 25) underwent IUD placement </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: There was a high prevalence of menstrual problems among this sample of severely <z:mp ids='MP_0001261'>obese</z:mp> adolescent females </plain></SENT>
<SENT sid="13" pm="."><plain>The majority accepted the IUD, indicating it is a viable option among this population </plain></SENT>
</text></document>